Journal of the Korean Pediatric Society 1998;41(2):216-223.
Published online February 15, 1998.
High Dose of Amphotericin B in Intralipid Emulsion-based Delivery System in Immunocompromised Children with Invasive Fungal Infections
Geun Mo Kim, Hoon Kook, Sung Ho Cho, Ji Yong Park, Young Jong Woo, Tai Ju Hwang
Department of Pediatrics, College of Medicine, Chonnam University, Kwangju, Korea
침습성 진균증이 발생한 소아 혈액종양 환자에서 Intralipid 유탁액 고용량 Amphotericin B 치료 경험
김근모, 국훈, 조성호, 박지영, 우영종, 황태주
전남대학교 의과대학 소아과학교실
Correspondence: 
Geun Mo Kim, Email: 1
Abstract
Purpose
: Fungal infections are an important cause of morbidity and mortality in patients with hematologic malignancies. The therapy of choice in documented or suspected invasive fungal infections has been intravenous Amphotericin B(AmB). Adverse effects such as fever, chills, thrombophlebitis, nausea or vomiting are common. A more serious adverse effect is potential renal impairment. As AmB administration mixed with Intralipid(AmB/Intralipid) was reported to decrease AmB toxicity without a concomitant loss of antifungal efficacy, we studied the efficacy and side effects of long-term administration of AmB/Intralipid in leukemic children with invasive fungal diseases.
Methods
: AmB/Intralipid was administered in seven leukemic children(male, 3; female, 4) who had invasive fungal infections between July 1994 and March 1997.
Results
: AmB/Intralipid was administered at a mean concentration of 1.45mg/kg/day for a mean of 58.1 days with cumulative dose of 3.01g. Excluding 2 patients who succumbed to the underlying leukemia, 4 out of 5 remaining patients remained free of both fungal infection and leukemia. Chills associated with AmB/Intralipid were found 13 times in 4 patients. One patient could not continue the administration because of the chills on the 45th day of AmB/Intralipid. Renal and hepatic impairment greater than Grade II toxicity was found in each case, respectively. The other 6 patients showed mild elevation from the baseline, but remained within the normal limits.
Conclusion
: Long-term, high-dose AmB/Intralipid therapy can be safely and effectively used in immunocompromised children with invasive fungal infections.
Key Words: High dose amphotericin B, Renal toxicity, Intralipid amphotericin B, Invasive fungal infection


METRICS Graph View
  • 1,905 View
  • 4 Download


Close layer
prev next